PDRN in Skincare: Does Salmon DNA Really Work on Your Face?

From injectable skin boosters to the latest skincare serums, PDRN is everywhere. But what does the science actually say, and can a topical cream deliver the same benefits as an injection? If you are weighing up topicals, koppā's GHK-Cu 2% High Potency Serum is built on GHK-Cu, a copper peptide with more than four decades of research behind it, at 2% stated on the label.

There is always a new ingredient having its moment in skincare.

Some arrive with decades of research behind them. Others seem to appear overnight, accompanied by enthusiastic testimonials, impressive before-and-after photographs, and a rather generous interpretation of the word proven.

Right now, that ingredient is PDRN.

Also known as polydeoxyribonucleotide, PDRN is making its way into serums, moisturizers, masks and just about anything else that can accommodate another skincare acronym.

And then there’s the part that makes everyone stop scrolling.

Salmon DNA.

Yes, really.

But before we dismiss it as another rather bizarre beauty trend, there’s something worth understanding. PDRN has a legitimate scientific history, particularly in tissue repair and regenerative medicine. And certain injectable skin treatments have demonstrated measurable benefits in clinical studies.

So the science isn’t imaginary.

The question is whether the benefits demonstrated through injections can also be achieved by applying PDRN to the surface of the skin.

That deserves a closer look.

What exactly is PDRN?

PDRN stands for polydeoxyribonucleotide. It consists of purified DNA fragments, traditionally obtained from salmon or trout reproductive tissue.

Before anyone imagines rubbing fish sperm directly onto their face, that’s not quite what’s happening. Cosmetic and medical preparations use processed, purified DNA-derived material.

Researchers have investigated PDRN for its potential to support tissue repair through two biological mechanisms.

The first involves adenosine A2A receptor signaling, a pathway associated with regulating inflammation and promoting tissue repair.

The second involves the nucleotide salvage pathway, through which cells can reuse molecular building blocks needed to produce DNA during normal cellular maintenance and repair.

In laboratory and clinical research, PDRN has been associated with wound healing, tissue recovery and processes involved in maintaining healthy skin structure.

Importantly, PDRN does not simply replace damaged DNA in your skin. That would be a rather impressive claim, but it isn’t how this ingredient works.

Its potential lies in influencing biological processes that support tissue repair.

And there is evidence for those effects.

What is the strongest evidence for PDRN?

This is where PDRN’s scientific credentials become genuinely interesting.

Long before it became a trending skincare ingredient, researchers were investigating injectable PDRN for wound healing.

In a 2014 randomized, double-blind clinical trial published in The Journal of Clinical Endocrinology & Metabolism (https://doi.org/10.1210/jc.2013-3569)⁠, researchers studied 216 patients with difficult-to-heal diabetic foot ulcers.

Participants received either PDRN or a placebo, administered through intramuscular injections and injections around the affected area.

After eight weeks:

37.3% of patients in the PDRN group achieved complete wound healing.
18.9% of patients in the placebo group achieved complete healing.
Median time to complete healing was 30 days with PDRN, compared with 49 days in the placebo group.

That’s a meaningful clinical result.

Of course, treating a diabetic foot ulcer is not the same thing as reducing the appearance of crow’s feet. The study doesn’t prove that PDRN reverses facial aging.

What it demonstrates is something important: PDRN can produce measurable biological effects when delivered appropriately.

And that helps explain why researchers began exploring related DNA-derived treatments in aesthetic medicine.

What about injectable PDRN skin boosters?

You may have heard of polynucleotide skin boosters, particularly treatments that have gained popularity in Korean aesthetic medicine.

This is where terminology becomes a little confusing.

PDRN and PN (polynucleotides) are related, but they are not necessarily identical preparations.

Both involve DNA-derived materials, but they can differ in molecular size, fragment length, formulation and intended use.

Many injectable aesthetic products use polynucleotides rather than the specific shorter-fragment preparations commonly described as PDRN.

That distinction matters when interpreting research.

In a 2020 randomized, double-blind, split-face clinical trial (https://pubmed.ncbi.nlm.nih.gov/32248707/)⁠, 27 participants received polynucleotide injections on one side of the periocular area and non-crosslinked hyaluronic acid injections on the other.

Researchers observed improvements in several skin-quality measurements. The polynucleotide-treated side showed greater improvement in certain measures, including skin roughness and pore volume, although not all outcomes differed significantly between treatments.

A 2025 systematic review published in the Journal of Cosmetic Dermatology (https://doi.org/10.1111/jocd.16721)⁠ examined nine studies involving 219 patients receiving polynucleotide treatments.

The researchers reported encouraging findings for wrinkles, skin texture and elasticity, while noting that the quality of the available evidence ranged from low to moderate.

More recently, a 2026 systematic review of randomized clinical trials (https://pubmed.ncbi.nlm.nih.gov/42572627/)⁠ examined seven studies involving 183 participants across skin rejuvenation, scar prevention and wound healing.

The most consistent benefits were observed in wound-healing applications, while results relating to aesthetic rejuvenation remained promising but less conclusive.

So yes, there is legitimate clinical evidence behind injectable DNA-derived treatments.

The results are encouraging, particularly for certain skin-quality concerns. But the evidence is not equally strong for every formulation, indication or claim about long-term rejuvenation.

And now we arrive at the important question: what happens when we put PDRN into a serum instead of injecting it into the skin?

Does topical PDRN actually work?

This is where things become considerably more complicated.

Our skin has a very effective protective barrier. It’s designed to keep moisture in and potentially harmful substances out.

Unfortunately for skincare formulators, that barrier also makes it difficult for certain beneficial ingredients to reach the deeper layers of skin.

PDRN preparations contain relatively large DNA fragments, and molecular size presents a potential obstacle to penetration.

An injection bypasses that barrier.

A serum doesn’t.

For years, this has been one of the main questions surrounding topical PDRN: can enough of the material reach the appropriate skin layers to produce meaningful biological benefits?

Until recently, the evidence supporting topical use was considerably thinner than the evidence supporting injectable treatments.

But research published in 2026 has made the conversation more interesting.

A 2026 study challenges what we thought about topical PDRN

In July 2026, researchers published a study in PLOS ONE investigating whether a specific medium-length PDRN preparation could penetrate skin and improve signs of photodamage.

The study, titled Topical medium-length PDRN enhances dermal extracellular matrix repair in photodamaged skin (https://doi.org/10.1371/journal.pone.0350905)⁠, combined laboratory testing, skin-penetration experiments and a human clinical trial.

The clinical portion involved 31 women aged 35 to 55.

Participants applied a cream containing 0.1% PDRN to one side of the eye area and a cream containing 0.1% retinol to the other, twice daily for 28 days.

Researchers reported greater improvement with the PDRN formulation in several measurements, including periocular wrinkles, dermal thickness and density.

Laboratory investigations also suggested that PDRN-associated material could move beyond the outer skin barrier into viable skin layers.

That’s significant.

It challenges the idea that topical PDRN is automatically ineffective because of molecular size.

But there are important limitations.

The clinical study was small and lasted only four weeks. There was no plain-cream control group, which makes it harder to distinguish the active ingredient’s effects from those of the overall formulation.

The researchers also acknowledged that further studies are needed to establish whether the observed improvements represent lasting changes in skin structure rather than shorter-term hydration or plumping effects.

And importantly, the findings concern one specific PDRN preparation and formulation. They cannot automatically be applied to every serum advertising PDRN on its label.

Still, I think this is exciting research.

Not proof that every PDRN serum works, but evidence that topical delivery may be possible under certain conditions.

There is a difference.

What about plant-derived or vegan PDRN?

As if salmon DNA wasn’t enough to discuss, we now have plant-derived versions entering the skincare conversation.

These are often marketed as vegan PDRN.

One particularly interesting study published in December 2025 in the International Journal of Molecular Sciences (https://doi.org/10.3390/ijms27010220)⁠ investigated low-molecular-weight PDRN derived from Paeonia lactiflora, commonly known as peony.

Researchers examined its effects in laboratory models and a small human investigation.

They reported improved skin-barrier recovery after two weeks in a 10-person skin-damage model, along with improvements in periocular elasticity following four weeks of topical treatment.

Again, promising.

But this was an early investigation involving a particular plant-derived preparation, not proof that every vegan PDRN product behaves like salmon-derived PDRN.

The source of an ingredient, its molecular characteristics and the way it is formulated can influence its biological activity.

Simply sharing the same ingredient name doesn’t guarantee identical results.

Why does formulation matter more than the marketing?

I think this is one of the most overlooked aspects of modern skincare.

We become fascinated with individual ingredients while forgetting that we are not applying isolated laboratory materials to our faces.

We’re applying finished formulations.

A product might contain PDRN, but that tells us very little about how much it contains, the characteristics of that particular PDRN preparation, or whether the formulation helps it reach the skin layers where it is intended to work.

It also matters what else is in the product.

If a PDRN serum contains glycerin, hyaluronic acid, niacinamide and other well-established moisturizing ingredients, improvement in hydration or the appearance of fine lines doesn’t necessarily demonstrate that PDRN itself was responsible.

That doesn’t make the product ineffective.

It simply means we should be careful about attributing the results to one ingredient.

When assessing any topical PDRN product, I would want to know:

What type and source of PDRN does it contain?
Is the concentration disclosed?
Has the finished formulation been clinically tested?
Does the research involve intact human skin, or was the ingredient delivered through injections, microneedling or another procedure?
Were the results compared with an appropriate control formulation?

These are reasonable questions.

They are also questions that apply to almost every active skincare ingredient, not just PDRN.

Why is everyone suddenly talking about PDRN?

The scientific history of PDRN is certainly not new, but its popularity in consumer skincare has accelerated dramatically.

PDRN interest has surged

37.2 million average monthly interactions across Google, TikTok and Instagram, up 609.8% year over year.

According to beauty trend intelligence company Spate, PDRN is generating approximately 37.2 million average monthly interactions across Google, TikTok and Instagram, representing 609.8% year-over-year growth.

Spate’s 2026 analysis of PDRN consumer trends (https://www.spate.nyc/blog/pdrn-in-skincare-what-the-consumer-data-tells-beauty-brands-about-the-next-big-active)⁠ also forecasts further growth of 34.4% over the following year.

That’s a remarkable amount of attention for an ingredient many consumers would never have heard of a few years ago.

Spate also identifies growing consumer interest in PDRN for mature skin, fine lines and other skin concerns.

And it’s not difficult to understand the appeal.

PDRN sits at the intersection of several things consumers are increasingly interested in: regenerative skincare, skin longevity, Korean beauty innovation and ingredients backed by scientific research.

It also has a rather memorable origin story.

Salmon DNA is certainly more likely to stop someone scrolling than another discussion about moisturizers.

But popularity and scientific proof are two different things.

A viral ingredient can be genuinely useful. It can also be marketed far beyond what the available evidence supports.

Both can be true at the same time.

Is PDRN worth the attention?

I think it is.

Not because it’s trending, and certainly not because salmon DNA sounds particularly glamorous.

It’s worth paying attention to because there is real scientific investigation behind it, and new topical research is beginning to address questions that have remained unanswered for years.

But I’m not convinced that every promising ingredient immediately needs to become an essential part of our skincare routines.

We already have enough products competing for space on our bathroom shelves.

I’d rather understand what an ingredient can do, how it works, and whether there’s sufficient evidence to justify using it consistently.

And I’m perfectly comfortable admitting when the research is still developing.

In fact, I’d argue that’s exactly what a science-led approach to skincare should look like.

Where koppā fits in your routine

And that brings me to GHK-Cu, the copper peptide at the heart of koppā. While newer ingredients continue to capture the skincare industry’s attention, GHK-Cu has been investigated for more than four decades. Its role in collagen and elastin synthesis and cellular signaling has been explored in a substantial body of research, including the 2018 scientific review of its regenerative and protective actions (https://doi.org/10.3390/ijms19071987)⁠ and a 2026 systematic review examining its biological mechanisms and clinical evidence (https://pubmed.ncbi.nlm.nih.gov/42787770/)⁠, much of it laboratory and preclinical work. There is something reassuring about building a skincare philosophy around an ingredient with such a long history of scientific investigation. It’s why we chose GHK-Cu as the foundation of koppā: we believe in supporting the health and longevity of the skin we live in.

Our GHK-Cu 2% High Potency Serum puts that into one water-light, fragrance-free step: 2% GHK-Cu, stated on the label, with six additional peptides, Hydrolyzed Collagen and Collagen, in a 45 ml bottle, 50% more than a 30 ml serum. It absorbs quickly with a non-greasy finish. Use 3 to 4 drops on clean skin, face and neck, morning and night.

To start, smooth 3 to 4 drops over clean skin on your face and neck, morning and night, then follow with your moisturizer.

Chantelle- koppā founder.

Frequently asked questions

Is PDRN scientifically proven to work?

PDRN has demonstrated benefits in human clinical studies, particularly for certain wound-healing applications. Related injectable polynucleotide treatments have also shown promising improvements in skin quality. Evidence for topical PDRN is emerging, but remains more limited and formulation-specific.

Can topical PDRN penetrate the skin?

Penetration depends on factors including molecular size and formulation. A 2026 study reported evidence of PDRN-associated material reaching viable skin layers. However, more research is needed to establish how reliably different commercial formulations deliver biologically active material.

Is topical PDRN as effective as injectable PDRN?

There is currently insufficient evidence to conclude that topical PDRN produces results comparable with injectable treatments. Injections bypass the skin’s protective barrier, while topical formulations must overcome it.

Does PDRN stimulate collagen production?

Laboratory studies suggest that certain PDRN preparations can influence pathways associated with collagen synthesis and extracellular matrix repair. Some human studies have reported improvements in skin structure, but longer-term clinical evidence is needed to confirm the extent of new collagen formation following topical application.

Is PDRN better than GHK-Cu?

There is currently insufficient head-to-head clinical evidence to establish whether PDRN or GHK-Cu is more effective for general skin rejuvenation. Both have been investigated for their roles in tissue repair and skin health, but they differ in molecular structure, mechanisms and the clinical evidence available for specific applications.

What is in koppā’s GHK-Cu 2% High Potency Serum?

It contains 2% GHK-Cu (copper tripeptide-1), stated on the label, with six additional peptides, Hydrolyzed Collagen and Collagen, in a water-light, fragrance-free formula. A 45 ml bottle is $75, 50% more than a 30 ml serum. Use 3 to 4 drops on clean skin, face and neck, morning and night.

The short version

Injected PDRN has the strongest clinical support, led by a 2014 trial in which 37.3% of patients with diabetic foot ulcers achieved complete wound healing with PDRN, against 18.9% with placebo. Topical PDRN is early but interesting: one 2026 PLOS ONE study of 31 women reported promising results for one specific formula. If you want a peptide with a longer research record in your routine today, GHK-Cu has been studied for more than four decades. Start with 3 to 4 drops of koppā's GHK-Cu 2% High Potency Serum on clean skin, face and neck, morning and night.

⸻

Sources and Further Reading

PDRN: Injectable Treatments and Clinical Research

1. PDRN and Wound Healing (2014)
The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers.
The Journal of Clinical Endocrinology & Metabolism.
Read the clinical study (https://doi.org/10.1210/jc.2013-3569)⁠

2. Polynucleotide Injections for Periocular Rejuvenation (2020)
Randomized, double-blind, split-face clinical trial comparing polynucleotides with hyaluronic acid.
Read the clinical study (https://pubmed.ncbi.nlm.nih.gov/32248707/)⁠

3. The Effectiveness of Polynucleotides in Esthetic Medicine (2025)
Systematic review examining clinical outcomes in aesthetic treatments.
Journal of Cosmetic Dermatology.
Read the systematic review (https://doi.org/10.1111/jocd.16721)⁠

4. Polynucleotides and PDRN for Skin Rejuvenation, Scar Prevention and Wound Healing (2026)
Systematic review of randomized clinical trials.
Read the systematic review (https://pubmed.ncbi.nlm.nih.gov/42572627/)⁠

PDRN: Topical Application and Skin Penetration

5. Topical Medium-Length PDRN and Photodamaged Skin (2026)
Clinical and laboratory research investigating skin penetration and dermal extracellular matrix changes.
PLOS ONE.
Read the study (https://doi.org/10.1371/journal.pone.0350905)⁠

6. Plant-Derived PDRN and Skin Aging (2025)
Anti-Aging Efficacy of Low-Molecular-Weight Polydeoxyribonucleotide Derived from Paeonia lactiflora.
International Journal of Molecular Sciences.
Read the study (https://doi.org/10.3390/ijms27010220)⁠

GHK-Cu: Scientific Research

7. Pickart & Margolina (2018)
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
International Journal of Molecular Sciences.
Read the scientific review (https://doi.org/10.3390/ijms19071987)⁠

8. GHK-Cu Mechanisms and Therapeutic Applications (2026)
Systematic review examining GHK-Cu research and topical microneedle delivery.
Read the systematic review (https://pubmed.ncbi.nlm.nih.gov/42787770/)⁠

Consumer Trends and Industry Research

9. Spate (2026)
PDRN in Skincare: What the Consumer Data Tells Beauty Brands About the Next Big Active.
Analysis of PDRN consumer interest, online discussions and skincare trends.
Read the Spate article (https://www.spate.nyc/blog/pdrn-in-skincare-what-the-consumer-data-tells-beauty-brands-about-the-next-big-active)⁠

10. Spate, October 2026
What Brands Need to Know About PDRN.
Industry report on social media trends and consumer interest in PDRN.
Access the Spate report (https://hubs.la/Q04zvpZL0)⁠